Scientists plumbed the depths of nearly 3,000 soil samples from around the globe to compile the heftiest atlas of soil viruses ever created.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Input from humans helps when deciding whether to trust the recommendations or decisions of a machine-learning system.

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

Grid modernization, improved energy storage goals of agreement between PNNL and East Coast energy company.

PNNL will lead two new projects to advance resilient distribution systems and partner on three additional demonstrations aimed at validating new approaches and technologies to make the aging grid more resilient and secure.

PNNL chief engineer, Jeff Dagle, helps roll out National Academies report on grid resilience.

PNNL is helping to create open-access power grid datasets for use in testing new grid technologies.

PNNL researchers get new opportunities to shape the country’s power grid for the future.